Get the Stockscreener App
99.15
1.00%
-1.00
After Hours:
100.06
0.91
+0.92%
Abivax Adr stock is traded at $99.15, with a volume of 1.70M.
It is down -1.00% in the last 24 hours and down -12.68% over the past month.
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
See More
Previous Close:
$100.15
Open:
$100.55
24h Volume:
1.70M
Relative Volume:
1.11
Market Cap:
$7.91B
Revenue:
-
Net Income/Loss:
$-386.19M
P/E Ratio:
-18.87
EPS:
-5.2547
Net Cash Flow:
$-206.27M
1W Performance:
-1.71%
1M Performance:
-12.68%
6M Performance:
-12.73%
1Y Performance:
+1,539%
1-Day Range:
$97.83
$101.49
1-Week Range:
$95.70
$103.93
52-Week Range:
$5.69
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
99.15 | 7.99B | 0 | -386.19M | -206.27M | -5.2547 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 116.49B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.73B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 55.49B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.75B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 33.54B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-16-26 | Initiated | Jefferies | Buy |
| Feb-24-26 | Initiated | Wedbush | Outperform |
| Nov-24-25 | Initiated | Truist | Buy |
| Nov-06-25 | Initiated | Wolfe Research | Outperform |
| Oct-13-25 | Initiated | Barclays | Overweight |
| Jul-23-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-25 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jul-29-24 | Initiated | Laidlaw | Buy |
| May-20-24 | Initiated | BTIG Research | Buy |
| Apr-29-24 | Initiated | Guggenheim | Buy |
| Apr-29-24 | Initiated | Piper Sandler | Overweight |
| Nov-14-23 | Initiated | Leerink Partners | Outperform |
| Nov-14-23 | Initiated | Morgan Stanley | Equal-Weight |
View All
Abivax Adr Stock (ABVX) Latest News
Abivax Soars As New Crohn’s Trial Ignites Hopes - TipRanks
Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Why Abivax SA Sponsored ADR Stock Is Sinking - TipRanks
Why Abivax Shares Are Sinking Despite Trial Success - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
ABIVAX SA-ADR (ABVX) Stock Chart - ChartMill
What's Going On With Abivax Stock On Thursday? - Benzinga
ABVX Technical Analysis | Trend, Signals & Chart Patterns | ABIVAX SA-ADR (NASDAQ:ABVX) - ChartMill
Abivax SA sponsored ADR (ABVX) loses 41.4% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Abivax SA Sponsored ADR (ABVX) Loses 41.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday - Sahm
Why Abivax SA Sponsored ADR Shares Are Sinking - TipRanks
Why This Biotech Plummeted Despite Its 'Best-Case' Study - Investor's Business Daily
Truist cuts Abivax stock price target on malignancy concerns By Investing.com - Investing.com Australia
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Abivax shares sink as rare malignancy events cloud strong colitis trial data - Investing.com UK
Why Abivax SA Sponsored ADR Shares Are Sliding - TipRanks
Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
What makes Abivax SA sponsored ADR (ABVX) a strong momentum stock: Buy now? - MSN
ABVX Q4 2025 Earnings: Wider-Than-Expected Loss Highlights Clinical-Stage Biotech ChallengesWeak Earnings Momentum - The Legal Advocate
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and TG Therapeutics (TGTX) - The Globe and Mail
What Makes Abivax SA Sponsored ADR (ABVX) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
ABVXAbivax ADR Stock Price and Quote - Finviz
Abivax reports Q1 results, ulcerative colitis trial data - Investing.com
Abivax Shareholders Approve 2025 Accounts and Governance Resolutions at May 11 AGM - The Globe and Mail
Abivax SA Sponsored ADR (ABVX) Receives a Buy from Barclays - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI), Immunic (IMUX) and Protara Therapeutics (TARA) - The Globe and Mail
Brummer Multi Strategy AB Acquires Shares of 14,375 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst - The Globe and Mail
Abivax SA Sponsored ADR $ABVX Shares Acquired by Nan Fung Trinity HK Ltd. - MarketBeat
Abivax Buys Back $90 Million in Royalties via $45 Million ADS Offering, Keeps Cash Runway to Q4 2027 - The Globe and Mail
Number of shareholders of Abivax SA Sponsored ADR – TRADEGATE:2X10 - TradingView
Why Abivax SA Sponsored ADR Shares Are Under Pressure - TipRanks
Jennison Associates LLC Buys Shares of 127,907 Abivax SA Sponsored ADR $ABVX - MarketBeat
Pictet Asset Management Holding SA Sells 72,387 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Total Clarity Wealth Management Inc. Acquires Shares of 9,245 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Sees Large Drop in Short Interest - MarketBeat
Why Abivax SA Sponsored ADR Shares Keep Sliding - TipRanks
ABVX soars pre-market on reports of $17.5 billion Eli Lilly takeover interest - MSN
UBS Group AG Has $596.59 Million Stock Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
China Universal Asset Management Co. Ltd. Purchases Shares of 11,619 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Regeneron (REGN) - The Globe and Mail
Abivax Publishes Preparatory Documents for May 11, 2026 General Meeting - TipRanks
Tudor Investment Corp ET AL Buys New Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Why Abivax SA Sponsored ADR Shares Are Surging - TipRanks
Harbor Capital Advisors Inc. Takes Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax Adr Stock (ABVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):